Cargando…

Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line.

Studies were carried out in a variant human multidrug-resistant (MDR) cell line CEM/A7R, which expresses very low levels of mdr1 mRNA and P-glycoprotein (P-gp). The induction of mdr1 RNA expression by three anthracyclines, (doxorubicin, daunorubicin, epirubicin), VP-16 and two vinca alkaloids (vincr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, X. F., Slater, A., Wall, D. M., Kantharidis, P., Parkin, J. D., Cowman, A., Zalcberg, J. R.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1995
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033794/ https://www.ncbi.nlm.nih.gov/pubmed/7734315

Ejemplares similares

Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line
por: Hu, X F, et al.
Publicado: (1999)

Inheritance of chromosome 7 is associated with a drug-resistant phenotype in somatic cell hybrids.
por: de Silva, M., et al.
Publicado: (1996)

Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925
por: Yang, X, et al.
Publicado: (2014)

Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
por: Hasegawa, S., et al.
Publicado: (1995)

Differential recognition of mdr1a and mdr1b gene products in multidrug resistant mouse tumour cell lines by different monoclonal antibodies.
por: Barrand, M. A., et al.
Publicado: (1992)

Comparison of characteristics and mortality in multidrug resistant (MDR) and non-MDR tuberculosis patients in China
por: Sun, Yanni, et al.
Publicado: (2015)

The effect of varying multidrug-resistence (MDR) definitions on rates of MDR gram-negative rods
por: Wolfensberger, Aline, et al.
Publicado: (2019)

Multidrug resistance (mdr) genes in human cancer.
por: Nooter, K., et al.
Publicado: (1991)

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
por: Ali, Monadil H., et al.
Publicado: (2019)

The anthracycline resistance-associated (ara) gene, a novel gene associated with multidrug resistance in a human leukaemia cell line.
por: Longhurst, T. J., et al.
Publicado: (1996)

Regulation and expression of multidrug resistance (MDR) transcripts in the intestinal epithelium
por: Li, M, et al.
Publicado: (1999)

Novel strategies to prevent the development of multidrug resistance (MDR) in cancer
por: Wang, Jinglu, et al.
Publicado: (2017)

Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies
por: Catalano, Alessia, et al.
Publicado: (2022)

Study of the prevalence of Multidrug-Resistant Pulmonary Tuberculosis (MDR-TB) in Western Rajasthan using line probe assay
por: Sharma, Mukesh, et al.
Publicado: (2020)

Epoxylathyrane Derivatives as MDR-Selective Compounds for Disabling Multidrug Resistance in Cancer
por: Reis, Mariana Alves, et al.
Publicado: (2020)

Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines.
por: Coley, H. M., et al.
Publicado: (1993)

Evaluation of the frequency of mutation genes in multidrug-resistant tuberculosis (MDR-TB) strains in Beijing, China
por: Liu, Y., et al.
Publicado: (2021)

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda
por: Albert, Heidi, et al.
Publicado: (2010)

Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents
por: Feng, Senling, et al.
Publicado: (2020)

Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR–CML cell lines?
por: Rumjanek, Vivian M., et al.
Publicado: (2013)

Multidrug Resistance in Rat Colon Carcinoma Cell Lines CC531, CC531(mdr+) and CC531(rev)
por: Gheuens, Eric, et al.
Publicado: (1993)

1063. ARGONAUT-V: Susceptibility of Multidrug-Resistant (MDR) Pseudomonas aeruginosa to Cefepime-Taniborbactam
por: Mack, Andrew R, et al.
Publicado: (2021)

P388 leukaemia cells resistant to the anthracycline menogaril lack multidrug resistant phenotype.
por: Badiner, G. J., et al.
Publicado: (1990)

Cross-talk between signalling pathways and the multidrug resistant protein MDR-1
por: Ding, S, et al.
Publicado: (2001)

Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids
por: Limtrakul, Pornngarm, et al.
Publicado: (2004)

Functional Evidence of Multidrug Resistance Transporters (MDR) in Rodent Olfactory Epithelium
por: Molinas, Adrien, et al.
Publicado: (2012)

Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
por: Sabur, Natasha F., et al.
Publicado: (2021)

Virulence Potential and Treatment Options of Multidrug-Resistant (MDR) Acinetobacter baumannii
por: Kumar, Sunil, et al.
Publicado: (2021)

A Case of Multidrug-Resistant (MDR) Tuberculosis and HIV Co-Infection
por: Vila Torres, Sebastian G, et al.
Publicado: (2023)

A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposide.
por: Philip, P. A., et al.
Publicado: (1992)

Efficacy of moxifloxacin & econazole against multidrug resistant (MDR) Mycobacterium tuberculosis in murine model
por: Gupta, U.D., et al.
Publicado: (2015)

Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?
Publicado: (1996)

Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy?
por: Chau, I, et al.
Publicado: (2003)

The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas
por: Briski, R, et al.
Publicado: (2014)

Anti-Cripto Mab inhibit tumour growth and overcome MDR in a human leukaemia MDR cell line by inhibition of Akt and activation of JNK/SAPK and bad death pathways
por: Hu, X F, et al.
Publicado: (2007)

Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali()
por: Baya, Bocar, et al.
Publicado: (2019)

Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: A five year follow-up analysis
por: Mignogna, Chiara, et al.
Publicado: (2006)

Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression.
por: Coley, H. M., et al.
Publicado: (1991)

Modulation of vinblastine sensitivity by dipyridamole in multidrug resistant fibrosarcoma cells lacking mdr1 expression.
por: Shalinsky, D. R., et al.
Publicado: (1991)

Amplification and expression of mdr1 gene in a multidrug resistant variant of small cell lung cancer cell line NCI-H69.
por: Reeve, J. G., et al.
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_g6p7c3dqptqfrj1p8vj7mks2ce